IMPROVING THE LIVES OF PATIENTS WITH BRAIN TUMORS 

©2019 GT Medical Technologies, Inc. I All Rights Reserved 

  • LinkedIn Social Icon
  • Twitter Social Icon

Founders

Dr Brachman was instrumental in the development of GammaTile™ Therapy. He is a cofounder and the chief technology officer of GT Medical Technologies, as well as an inventor on all of the company’s product patents. A nationally recognized radiation oncologist and researcher, and the author of more than 50 peer-reviewed publications. His publishing credits include The Lancet, Cancer Research, and The New England Journal of Medicine. Dr Brachman is renowned for his extensive neuro-oncology clinical expertise.

 

Dr Brachman recently retired from practice after more than 15 years as the chairman and medical director of the Radiation Oncology department and codirector of the GammaKnife program at St. Joseph’s Hospital and Medical Center and Barrow Neurological Institute in Phoenix, Arizona. His considerable radiation oncology background includes a position as the professor of Radiation Oncology at the University of Arizona College of Medicine – Phoenix, and more than 15 years as a member of the NCI-sponsored Radiation Therapy Oncology Group CNS Tumor Steering Committee.

DAVID BRACHMAN, MD, FASTRO

Cofounder

PETER NAKAJI, MD

Cofounder

A neurosurgeon certified by the American Board of Neurosurgeons, and a member of the Society of Neurological Surgeons, Congress of Neurological Surgeons, and Arizona Neurological Society, Dr Nakaji is a pioneer in the area of neuroendoscopy for “keyhole” treatment. His clinical practice is focused on cranial neurosurgery including cerebrovascular surgery, minimally invasive and endoscopic cranial neurosurgery, and brain tumor surgery. As the program director of the Neurosurgery Residency Program at the Barrow Neurological Institute, Dr Nakaji oversees the largest neurosurgery residency training program in the United States.

HEYOUNG MCBRIDE, MD, MS

Cofounder

Dr McBride is a board-certified radiation oncologist who serves as the medical director of Radiation Oncology at Lovelace Health System, and as clinical associate professor at the University of Arizona College of Medicine – Phoenix and Barrow Neurological Institute. In addition to brachytherapy, Dr McBride has expertise in various forms. of stereotactic radiosurgery such as GammaKnife Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT).

 

A published author and recognized speaker, Dr McBride is a member of the American Brachytherapy Society, American Society of Clinical Oncology, Society of Gynecologic Oncology, and American Society for Radiation Oncology (ASTRO), where she serves on the Clinical Practice Guidelines Committee. Dr McBride is also a member of multiple national clinical trial groups and an active clinical researcher.

EMAD YOUSSEF, MD

Cofounder

Board certified in radiation oncology by the American Board of Radiology, Dr Youssef serves as an associate professor in the Neuroradiation Oncology department at the Barrow Neurological Institute and University of Arizona. In 2017, Dr Youssef was assigned as the medical director of Radiosurgery at BNI. 

 

During his career, Dr Youssef extensively researched and published papers on the use of radiation therapy to treat brain tumors. Over the last 10 years, Dr Youssef has treated thousands of patients with different brain tumors using various modalities of radiation therapy and radiosurgery including IMRT, GammaKnife, CyberKnife, and brachytherapy. 

 

Previously, Dr Youssef served as the medical director at the Arkansas Cancer Institute and as an assistant professor at the University of Arkansas for Medical Sciences (UAMS) College of Medicine.

THERESA THOMAS, MS, CCRC

Cofounder

Certified through the Association of Clinical Research Professionals, Ms Thomas is the program coordinator for Radiation Oncology at the Barrow Neurological Institute. Ms Thomas serves on the Brain Steering Committee and as a co-chair for the Protocol Support Committee at NRG Oncology. Previously, Ms Thomas was the director of Research at Arizona Oncology Services. A published author and well known to the NRG Oncology brain tumor community, Ms Thomas has more than 32 years of research experience.